JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma

JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China has approved the supplemental New Drug Application (sNDA) for its anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection (hereafter…

thaipr.net

11 ต.ค. 65

Shanghai Electric Jumps to 40th on ENR’s 2022 Top 250 International Contractors list

Shanghai Electric moved up to 40th place on the 2022 Top 250 International Contractors list released by Engineering News-Record (ENR), a world-renowned academic publication for news, analysis, commentary and data on the global engineering and construction industry.  The company placed 51st last year, rising swiftly to this higher position on the list in just a short period. […]

thaipr.net

9 ก.ย. 65
1 17 18 19 20 21 37